| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥5.39B | ¥5.23B | +3.1% |
| Cost of Sales | ¥3.02B | ¥3.05B | -0.8% |
| Gross Profit | ¥2.37B | ¥2.18B | +8.5% |
| SG&A Expenses | ¥1.22B | ¥1.20B | +1.5% |
| Operating Income | ¥1.09B | ¥944M | +15.9% |
| Non-operating Income | ¥30M | ¥27M | +13.0% |
| Non-operating Expenses | ¥2M | ¥818,000 | +162.3% |
| Ordinary Income | ¥1.12B | ¥970M | +15.7% |
| Profit Before Tax | ¥1.12B | ¥972M | +15.5% |
| Income Tax Expense | ¥355M | ¥311M | +13.9% |
| Net Income | ¥768M | ¥660M | +16.2% |
| Net Income Attributable to Owners | ¥767M | ¥622M | +23.3% |
| Total Comprehensive Income | ¥783M | ¥655M | +19.5% |
| Depreciation & Amortization | ¥29M | ¥42M | -31.0% |
| Interest Expense | ¥440,000 | ¥206,000 | +113.6% |
| Basic EPS | ¥146.33 | ¥118.66 | +23.3% |
| Dividend Per Share | ¥83.00 | ¥83.00 | +0.0% |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥14.14B | ¥14.80B | ¥-663M |
| Cash and Deposits | ¥8.68B | ¥8.34B | +¥341M |
| Accounts Receivable | ¥1.44B | ¥1.74B | ¥-303M |
| Inventories | ¥1.34B | ¥1.15B | +¥194M |
| Non-current Assets | ¥3.98B | ¥3.75B | +¥230M |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥567M | ¥663M | ¥-96M |
| Investing Cash Flow | ¥-2.39B | ¥-222M | ¥-2.17B |
| Financing Cash Flow | ¥-1.14B | ¥-845M | ¥-293M |
| Free Cash Flow | ¥-1.82B | - | - |
| Item | Value |
|---|---|
| Net Profit Margin | 14.2% |
| Gross Profit Margin | 43.9% |
| Current Ratio | 447.5% |
| Quick Ratio | 405.0% |
| Debt-to-Equity Ratio | 0.31x |
| Interest Coverage Ratio | 2486.36x |
| EBITDA Margin | 20.8% |
| Effective Tax Rate | 31.6% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | +3.1% |
| Operating Income YoY Change | +15.8% |
| Ordinary Income YoY Change | +15.6% |
| Net Income Attributable to Owners YoY Change | +23.3% |
| Total Comprehensive Income YoY Change | +19.5% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 5.30M shares |
| Treasury Stock | 55K shares |
| Average Shares Outstanding | 5.25M shares |
| Book Value Per Share | ¥2,642.06 |
| EBITDA | ¥1.12B |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥83.00 |
| Year-End Dividend | ¥91.00 |
| Segment | Revenue |
|---|---|
| HealthAndMedicalEquipment | ¥1.35B |
| IndustrialEquipment | ¥1.25B |
| ScienceEquipmentAndFacility | ¥2.79B |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥11.04B |
| Operating Income Forecast | ¥2.13B |
| Ordinary Income Forecast | ¥2.18B |
| Net Income Attributable to Owners Forecast | ¥1.49B |
| Basic EPS Forecast | ¥283.60 |
| Dividend Per Share Forecast | ¥138.00 |
| Property, Plant & Equipment | ¥2.03B | ¥2.00B | +¥27M |
| Intangible Assets | ¥108M | ¥21M | +¥87M |
| Investment Securities | ¥1.10B | ¥976M | +¥122M |
| Total Assets | ¥18.11B | ¥18.55B | ¥-433M |
| Current Liabilities | ¥3.16B | ¥3.89B | ¥-726M |
| Accounts Payable | ¥560M | ¥402M | +¥158M |
| Non-current Liabilities | ¥1.10B | ¥1.11B | ¥-12M |
| Total Liabilities | ¥4.26B | ¥4.99B | ¥-739M |
| Total Equity | ¥13.86B | ¥13.55B | +¥305M |
| Capital Stock | ¥787M | ¥787M | ¥0 |
| Capital Surplus | ¥866M | ¥866M | ¥0 |
| Retained Earnings | ¥12.13B | ¥11.84B | +¥290M |
| Treasury Stock | ¥-35M | ¥-35M | ¥-183,000 |
| Owners' Equity | ¥13.86B | ¥13.55B | +¥305M |
| Working Capital | ¥10.98B | - | - |